Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  liarozole fumarate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-7 of 7 for your search:
Start Over
Phase III Randomized Study of Liarozole Fumarate (R85246) vs PRED for Metastatic, Hormone-Refractory Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: YALE-HIC-7586, NCI-V95-0727
Phase II Study of Liarozole Fumarate for Unresectable or Metastatic Breast Cancer (Summary Last Modified 07/98)
Phase: Phase II
Type: Treatment
Status: Closed
Age: postmenopausal
Sponsor:
Protocol IDs: EORTC-10941
Phase II Pilot Study of Liarozole in Myelodysplastic Syndrome (Summary Last Modified 06/97)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: JRF-LIA-USA-31, NCI-V95-0745
Phase II Pilot Study of Liarozole in Progressive or Recurrent Squamous Cell Carcinoma of the Cervix (Summary Last Modified 06/97)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: JRF-LIA-USA-25, NCI-V95-0746
Phase II Pilot Study of Liarozole Fumarate for Recurrent non-Small Cell Lung Cancer (Summary Last Modified 08/96)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: YALE-HIC-8592, NCI-V96-0889
Phase II Randomized, Double-Blind Study of 3 Doses of Liarozole Fumarate in Patients with Rising PSA Levels After Definitive Local Treatment for Stage I/II/III Prostate Cancer (Summary Last Modified 02/98)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: JRF-LIA-INT-26, NCI-V97-1121
Phase II Multicenter Study of R-75251 in Patients with Progressive, Measurable, Metastatic Prostate Cancer (Summary Last Modified 12/91)
Phase: Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: EORTC-30902
Start Over